Sullivan William M's Form 4 filing
Privia Health Group, Inc. (PRVA) · filed Nov 23, 2022
- Accession no.
- 0000950103-22-020069
- Filed
- Nov 23, 2022
- Trade date
- Nov 21, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $6.43M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sullivan William MCIK 0001859839 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | Common Stock, $0.01 par value per share | SSaleDisposed | −285,027 | $22.56F2 | −$6,430,209.12 | 5,887,466 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This amount represents the $23.50 secondary public offering price per share of Common Stock of Privia Health Group, Inc., less the underwriting discount of $0.94 per share.
Referenced by the price of 1 transaction in Table I.